Vitaspring Biomedical Co. Ltd. (VSBC)

Price$0.0111Cached quote
VSBCOTC
Loading local price history

Financial charts

Revenue

Net income

Total cash / debt

CashTotal debt

Financial statements

10 annual periodsNewest to oldest
2026202520242023202220212020201920182017
Revenue$0$0$0$0$5.6M$248,200$15,140$17,180$16,230$0
Gross profit$0$0$0−$3.3M$2.1M$112,200$1,695$13,718$11,341$0
Gross margin————36.84%45.21%11.20%79.85%69.88%—
Operating expenses$385,411$679,914$1.1M$844,836$941,336——$36,114$17,714$45
Operating income−$385,411−$679,914−$1.1M−$4.2M$1.1M$425,382$6,919−$22,396−$6,374—
Operating margin————20.07%171.39%45.70%−130.36%−39.27%—
EBITDA−$375,454−$669,957−$1.1M−$4.2M$1.1M$425,382$7,369−$21,946−$5,999—
EBITDA margin————20.22%171.39%48.67%−127.74%−36.96%—
Net income−$415,368−$774,922−$1.1M−$4.2M$909,560$425,382$6,919−$22,396−$6,374−$45
Net profit margin————16.20%171.39%45.70%−130.36%−39.27%—
Basic EPSper basic share$0.00$0.00-$0.01-$0.02—$0.00$0.00$0.00$0.00$0.00
Diluted EPSper diluted share$0.00$0.00-$0.01-$0.02$0.00$0.00$0.00$0.00$0.00$0.00

Owners

Reported shareholders

Ownership data is not available for this listing yet.

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.

Community posts

It’s quiet here.

No posts about VSBC yet. Start the conversation.

Write the first post